Note 9 - Stock-Based Compensation

3 Months Ended

Mar. 31, 2026

Notes to Financial Statements

Shareholders' Equity and Share-Based Payments [Text Block]

9.	Stock-Based Compensation

Stock-based compensation expense for the three months ended March 31, 2026 and 2025 was allocated as follows:

		Three Months Ended March 31,
(in thousands)		2026				2025
Cost of revenues		$	6			$	30
Sales and marketing expenses			54				118
General and administrative expenses			155				359
Research and development expenses			42				93
Total stock-based compensation		$	257			$	600

As of March 31, 2026, the total compensation costs related to unvested awards not yet recognized was $2.2 million and the weighted average period over which it is expected to be recognized is approximately 2.2 years. The Company did not capitalize any stock-based compensation during these quarters.

Restricted stock unit (“RSU”) activity for the three months ended March 31, 2026 was as follows:

										Market-								Performance-
		Time-Based								Based								Based
		Restricted				Grant Date				Restricted				Grant Date				Restricted				Grant Date
		Stock Units				Fair Value				Stock Units				Fair Value				Stock Units				Fair Value
Balance at December 31, 2025			160,430			$	10.70				50,000			$	6.70				16,407			$	41.90
Granted			215,200				4.88				-				-				-				-
Vested			(13,670	)			38.71				-				-				-				-
Forfeited			(247	)			41.90				-				-				-				-
Balance at March 31, 2026			361,713			$	6.14				50,000			$	6.70				16,407			$	41.90

Retroactively presented to reflect 1-for-10 reverse stock split effective on March 13, 2026.

The aggregate fair value of RSUs that vested during the three months ended March 31, 2026, and 2025 was $0.1 million and $0.2 million, respectively. Unvested shares related to market-based and performance-based vesting conditions are reflected at 100% of their target vesting amount in the table above. Actual vesting could range from zero to 150% of their target amounts.

Performance-based RSU awards are contingent on the achievement of certain performance metrics. Compensation cost associated with performance-based RSUs are recognized based on the estimated number of shares that the Company ultimately expects will be earned. If the estimated number of shares to be earned is revised in the future, then stock-based compensation expense will be adjusted accordingly.

Stock option activity for the three months ended March 31, 2026 was as follows:

		Number of Options				Weighted-Average Exercise Price				Weighted-Average Remaining Contractual Term				Aggregate Intrinsic Value (in thousands)
Outstanding and exercisable at December 31, 2025			16,378			$	34.00
Cancelled/Forfeited			(2	)			32.10
Outstanding and exercisable at March 31, 2026			16,376			$	33.95				1.9			$	-

Retroactively presented to reflect 1-for-10reverse stock split effective on March 13, 2026.

There is no aggregate intrinsic value at March 31, 2026 because the Company’s closing stock price of $4.87 was below the exercise price of the outstanding options.